General Information of the Compound
| Compound ID |
CP0517070
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(4-chlorophenyl)methyl]-4-hydroxy-2-[methyl-[3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propyl]amino]butanamide
Show/Hide
|
||||||||||||||||||
| Formula |
C30H33ClN2O2
|
||||||||||||||||||
| Molecular Weight |
489.059
|
||||||||||||||||||
| Canonical SMILES |
CN(CCC=C1c2ccccc2CCc2ccccc12)C(CCO)C(=O)NCc1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H33ClN2O2/c1-33(29(18-20-34)30(35)32-21-22-12-16-25(31)17-13-22)19-6-11-28-26-9-4-2-7-23(26)14-15-24-8-3-5-10-27(24)28/h2-5,7-13,16-17,29,34H,6,14-15,18-21H2,1H3,(H,32,35)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ORAHIDQZAXCVOG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04790, Sodium- and chloride-dependent betaine transporter
Protein ID: PT03285, Sodium- and chloride-dependent GABA transporter 1
Protein ID: PT03076, Sodium- and chloride-dependent GABA transporter 3